Clarent Biopharma, Inc.
4 clinical trials · Sponsor
◉ Watch Clarent Biopharma, Inc.
| Record | Firm | Date |
|---|---|---|
| Oral CBP-0276 or Placebo in Adults With Active Psoriatic Arthritis (PsA) (NCT07706530) | Clarent Biopharma, Inc. | 2026-07-01 |
| CBP-0276 to Reduce Opioid Use in Adults Undergoing Major Orthopedic Surgery (NCT07687966) | Clarent Biopharma, Inc. | 2026-05-08 |
| Safety and Efficacy of CBP-0276 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects (NCT07204639) | Clarent Biopharma, Inc. | 2025-10-01 |
| Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects (NCT07708831) | Clarent Biopharma, Inc. | 2025-09-04 |
Track Clarent Biopharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.